Morgan Stanley Jazz Pharmaceuticals PLC Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Morgan Stanley holds 744,935 shares of JAZZ stock, worth $88.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

744,935

Previous 715,616 4.1%

Holding current value

$88.8 Million

Previous $76.4 Million 8.71%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $2.95 Million - $3.41 Million	29,319 Added 4.1%	744,935 $83 Million
Q2 2024 Oct 17, 2024	SELL	$103.94 - $118.98 $25.3 Million - $29 Million	-243,489 Reduced 25.39%	715,616 $76.4 Million
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $25.3 Million - $29 Million	-243,489 Reduced 25.39%	715,616 $76.4 Million
Q1 2024 Oct 17, 2024	BUY	$115.19 - $132.77 $28 Million - $32.3 Million	243,489 Added 34.03%	959,105 $115 Million
Q1 2024 Aug 16, 2024	BUY	$115.19 - $132.77 $20.8 Million - $23.9 Million	180,302 Added 23.15%	959,105 $115 Million
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $20.8 Million - $23.9 Million	180,302 Added 23.15%	959,105 $115 Million
Q4 2023 Aug 16, 2024	BUY	$114.26 - $136.0 $7.22 Million - $8.59 Million	63,187 Added 8.83%	778,803 $95.8 Million
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $4.23 Million - $5.03 Million	-37,014 Reduced 4.54%	778,803 $95.8 Million
Q3 2023 Nov 15, 2023	BUY	$122.0 - $145.31 $4.33 Million - $5.15 Million	35,456 Added 4.54%	815,817 $106 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $5.19 Million - $6.24 Million	42,370 Added 5.74%	780,361 $96.7 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $4.56 Million - $5.46 Million	33,998 Added 4.83%	737,991 $108 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $3.68 Million - $4.54 Million	28,383 Added 4.2%	703,993 $112 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.77 Million - $2.25 Million	13,955 Added 2.11%	675,610 $90.1 Million
Q2 2022 Oct 27, 2022	BUY	$141.59 - $168.66 $28 Million - $33.3 Million	197,519 Added 42.56%	661,655 $103 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $28 Million - $33.3 Million	197,519 Added 42.56%	661,655 $103 Million
Q1 2022 Oct 27, 2022	SELL	$129.64 - $160.7 $25.6 Million - $31.7 Million	-197,519 Reduced 29.85%	464,136 $72.3 Million
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $11.1 Million - $13.8 Million	-85,734 Reduced 15.59%	464,136 $72.3 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $11.8 Million - $14.3 Million	-98,489 Reduced 15.19%	549,870 $70.1 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $83.4 Million - $120 Million	648,359 New	648,359 $84.4 Million

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.47B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account